BioLine Rx Ltd (BLRX)
0.613
-0.02
(-3.74%)
USD |
NASDAQ |
Apr 24, 16:00
0.6131
0.00 (0.00%)
After-Hours: 07:41
BioLine Rx Total Liabilities (Quarterly): 50.70M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.70M |
| September 30, 2023 | 39.72M |
| June 30, 2023 | 37.88M |
| March 31, 2023 | 29.53M |
| December 31, 2022 | 25.54M |
| September 30, 2022 | 26.15M |
| June 30, 2022 | 11.27M |
| March 31, 2022 | 11.36M |
| December 31, 2021 | 13.30M |
| September 30, 2021 | 16.00M |
| June 30, 2021 | 17.44M |
| March 31, 2021 | 18.95M |
| December 31, 2020 | 25.26M |
| September 30, 2020 | 21.23M |
| June 30, 2020 | 23.76M |
| March 31, 2020 | 18.66M |
| December 31, 2019 | 20.19M |
| September 30, 2019 | 18.03M |
| June 30, 2019 | 20.18M |
| March 31, 2019 | 21.71M |
| December 31, 2018 | 14.91M |
| September 30, 2018 | 5.815M |
| June 30, 2018 | 6.027M |
| March 31, 2018 | 7.053M |
| December 31, 2017 | 8.084M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.102M |
| June 30, 2017 | 5.618M |
| March 31, 2017 | 5.402M |
| December 31, 2016 | 3.912M |
| September 30, 2016 | 3.668M |
| June 30, 2016 | 3.116M |
| March 31, 2016 | 2.939M |
| December 31, 2015 | 3.692M |
| September 30, 2015 | 4.36M |
| June 30, 2015 | 6.539M |
| March 31, 2015 | 5.685M |
| December 31, 2014 | 4.406M |
| September 30, 2014 | 4.093M |
| June 30, 2014 | 5.749M |
| March 31, 2014 | 6.747M |
| December 31, 2013 | 8.293M |
| September 30, 2013 | 8.063M |
| June 30, 2013 | 7.663M |
| March 31, 2013 | 10.40M |
| December 31, 2012 | 9.336M |
| September 30, 2012 | 9.901M |
| June 30, 2012 | 9.367M |
| March 31, 2012 | 11.19M |
| December 31, 2011 | 6.806M |
| September 30, 2011 | 6.681M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.27M
Minimum
Jun 2022
50.70M
Maximum
Dec 2023
23.43M
Average
20.19M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd | 55.78M |
| Pluri Inc | 34.95M |
| XTL Biopharmaceuticals Ltd | 0.162M |
| Can Fite Biofarma Ltd | 3.746M |
| BiomX Inc | 21.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.92M |
| Shareholders Equity (Quarterly) | 13.22M |
| Debt to Equity Ratio | 0.7391 |
| Current Ratio | 1.529 |
| Net Debt Paydown Yield | -0.11% |